Paul Hartmann AG
F:PHH2
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
213
257
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Paul Hartmann AG
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| DE |
|
Paul Hartmann AG
F:PHH2
|
774.3m EUR |
5%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8T JPY |
30%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.7B CHF |
14%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
126.8B DKK |
28%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD |
16%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.9B CNY |
38%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
15%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
2%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.3B CHF |
28%
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
806.2B JPY |
25%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.1B USD |
11%
|
Paul Hartmann AG
Glance View
Paul Hartmann AG engages in the production of medical and hygiene products. The company is headquartered in Heidenheim, Bayern and currently employs 10,628 full-time employees. The company went IPO on 2003-01-01. The firm operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Paul Hartmann AG's most recent financial statements, the company has Operating Margin of 4.6%.